Plovanic William J. 4
4 · OBALON THERAPEUTICS INC · Filed Oct 28, 2019
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-10-25+10,000→ 10,000 totalExercise: $1.75Exp: 2029-10-25→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The Option shall vest as to (i) 25% of the shares of Common Stock underlying the Stock Option on October 19, 2020 and (ii) 1/48th of the shares of Common Stock underlying the Stock Option on each monthly anniversary of October 19, 2020 thereafter, subject to the grantee's continued service with the Company through the applicable vesting date.